Topic

Articles

Strong collaboration critical as trial development advances.

Building Relationships Key for Smaller Sponsors 

Technology, talent and specialization add up to a plethora of industry M&As.

The Post-Pandemic CRO Landscape

A move back to in-house management of clinops could be on the horizon for sponsors.

Could Technology Supplant CROs?

A brief look at the market for mergers and acquisitions since the year of COVID.

The Tangled Web of Large Outsourced Providers 

New BDO CRO Insights Report reveals high rate of CRA turnover and what organizations are doing to combat it.

Turnover for Clinical Monitoring Remains High

Steven Bukvic, CEO of the ACROSS Global Alliance, speaks to Applied Clinical Trials about how it works to improve the clinical trial experience for smaller- and medium-sized sponsors.

Providing Greater Opportunity for Undersized CROs

The drug development sector is embracing technologies and digital methods that were previously not as widely used due to the COVID-19 global health crisis. 

Anticipating Digital Transformation of the Drug Development Workforce

Nearing a year into the pandemic, this article describes the legal concerns CRM encountered during the COVID-19 outbreak.

Legal Perspectives on Conducting Clinical Trials During COVID-19 Outbreak in Malaysia 

The success of a clinical study depends on the possibilities to involve the patient in the study. 

Rate of Patient Recruitment to International Multicenter Clinical Studies in Eastern Europe Countries

FDA’s Vaccines and Related Biological Products Advisory Committee addresses issues related to testing and approval of potential COVID vaccines.

CRO/Sponsor